Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Formosa Laboratories's EPS (Basic) for the
three
months ended in Jun. 2026 was NT$-0.12.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was NT$3.96.
During the past 3 years, the average EPS without NRIGrowth Rate was 0.40% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was -19.00% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was -1.90% per year.
During the past 13 years, Formosa Laboratories's highest 3-Year average EPS without NRI Growth Rate was 238.60% per year. The lowest was -66.50% per year. And the median was -5.00% per year.
Formosa Laboratories (TPE:4746) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Formosa Laboratories Earnings per Share (Diluted) Related Terms
Formosa Laboratories Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Formosa Laboratories's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Formosa Laboratories Earnings per Share (Diluted) Chart
TPE:4746 vs ZTS: Earnings per Share (Diluted) Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Formosa Laboratories's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Formosa Laboratories PE Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Formosa Laboratories's PE Ratio distribution charts can be found below:
* The bar in red indicates where Formosa Laboratories's PE Ratio falls into.
Formosa Laboratories Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Formosa Laboratories's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$3.94
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of NT$3.94 mean?
Formosa Laboratories (TPE:4746) has a Earnings per Share (Diluted) of NT$3.94 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Formosa Laboratories and its competitors. According to the industry distribution chart, Formosa Laboratories ranks #493 out of 785 companies in the Drug Manufacturers industry, placing it in the top 62.8%.
Is Formosa Laboratories' Earnings per Share (Diluted) too high?
Formosa Laboratories' current Earnings per Share (Diluted) is NT$3.94. Based on the distribution chart, Formosa Laboratories ranks #493 out of 785 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Formosa Laboratories has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Formosa Laboratories' Earnings per Share (Diluted) compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Formosa Laboratories ranks #493 out of 785 companies for Earnings per Share (Diluted). This places Formosa Laboratories in the lower half of its industry. The industry median Earnings per Share (Diluted) is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Drug Manufacturers company?
The median Earnings per Share (Diluted) among Drug Manufacturers companies is 9.60, based on 785 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Formosa Laboratories and its competitors. For the Drug Manufacturers industry, the median Earnings per Share (Diluted) is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Formosa Laboratories's current Earnings per Share (Diluted) is NT$3.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Formosa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Formosa Laboratories (TPE:4746) is currently considered Possible Value Trap. The stock's GF Value™ is NT$73.36, compared to a current price of NT$48.20 — trading 34.3% below its estimated fair value. The current Earnings per Share (Diluted) is NT$3.94. Formosa Laboratories' overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Formosa Laboratories (TPE:4746), the current Earnings per Share (Diluted) is NT$3.94 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Formosa Laboratories (TPE:4746) Overvalued in 2026?
Based on GuruFocus' analysis, Formosa Laboratories stock appears to be undervalued.
The current stock price of NT$48.20 is trading 34.3% below its estimated GF Value™ of NT$73.36.
GuruFocus considers Formosa Laboratories to be Possible Value Trap.
Key valuation signals for TPE:4746:
Earnings per Share (Diluted): NT$3.94
GF Value™: NT$73.36 vs. price of NT$48.20 (34.3% below fair value)
No single metric tells the full story. See the TPE:4746 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Formosa Laboratories Inc is mainly engaged in the wholesale and manufacturing of active pharmaceutical ingredients, as well as ultraviolet absorbers. The company geographically operates in India, Taiwan, Netherlands, Switzerland, Germany, Japan, China, Canada, United States, and Others.
76GF Score
Get the complete analysis for TPE:4746
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4746 has been successfully added to your 
